Mechanisms of Heightened Airway Sensitivity and Responses to Inhaled SO2 in Asthmatics

Environmental Health Insights

Volumn 9, Issue s1, 2015, Pages

  Reno, Anita L ^a   Brooks, Edward G ^b   Ameredes, Bill T ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

asthma; IL 10; sulfur dioxide

Indexed keywords

EID: 85074502206     PISSN: None     EISSN: 11786302     Source Type: Journal    
DOI: 10.4137/EHI.S15671     Document Type: Review

References (137)

1. WHO. Global Surveillance, Prevention and Control of Chronic Respiratory Diseases. Geneva, Switzerland: WHO Press; 2007: 15–6.
2. Rusconi F., Catelan D., Accetta G., Asthma symptoms, lung function, and markers of oxidative stress and inflammation in children exposed to oil refinery pollution. J Asthma. 2011; 48(1): 84–90. doi: 10.3109/02770903.2010.538106.
3. Smargiassi A., Goldberg M.S., Wheeler A.J., Associations between personal exposure to air pollutants and lung function tests and cardiovascular indices among children with asthma living near an industrial complex and petroleum refineries. Environ Res. 2014; 132: 38–45. doi: 10.1016/j.envres.2014.03.030.
4. Yang C., Wang J., Chan C., Hwang J., Chen P., Respiratory symptoms of primary school children living in a petrochemical polluted area in Taiwan. Pediatr Pulmonol. 1998; 25(5): 299–303.
5. Bloemen K., Verstraelen S., Van Den Heuvel R., Witters H., Nelissen I., Schoeters G., The allergic cascade: review of the most important molecules in the asthmatic lung. Immunol Lett. 2007; 113(1): 6–18. doi: 10.1016/j.imlet.2007.07.010.
6. Duramad P., Tager I.B., Holland N.T., Cytokines and other immunological biomarkers in children's environmental health studies. Toxicol Lett. 2007; 172(1-2): 48–59. doi: 10.1016/j.toxlet.2007.05.017.
7. Pandya R.J., Solomon G., Kinner A., Balmes J.R., Diesel exhaust and asthma: hypotheses and molecular mechanisms of action. Environ Health Perspect. 2002; 1101(suppl 1): 103–12.
8. Borish L., Aarons A., Rumbyrt J., Cvietusa P., Negri J., Wenzel S., Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol. 1996; 97(6): 1288–96.
9. Calhoun W., Hinton K., Brick J., Sharma A., Rosen W., Spontaneous and stimulated IL-10 release by alveolar macrophages (AM) but not blood monocytes (BM) is reduced in allergic asthmatics (AA). Am J Respir Crit Care Med. 1996; 153: A881.
10. Boldogh I., Bacsi A., Choudhury B.K., ROS generated by pollen NADPH oxidase provide a signal that augments antigen-induced allergic airway inflammation. J Clin Invest. 2005; 115(8): 2169–79. doi: 10.1172/JCI24422.during.
11. Liu L., Poon R., Chen L., Acute effects of air pollution on pulmonary function, airway inflammation, and oxidative stress in asthmatic children. Environ Health Perspect. 2009; 117(4): 668–74. doi: 10.1289/ehp11813.
12. Trasande L., Thurston G.D., The role of air pollution in asthma and other pediatric morbidities. J Allergy Clin Immunol. 2005; 115(4): 689–99. doi: 10.1016/j.jaci.2005.01.056.
13. White C.W., Martin J.G., Chlorine gas inhalation: human clinical evidence of toxicity and experience in animal models. Proc Am Thorac Soc. 2010; 7(4): 257–63. doi: 10.1513/pats.201001-008SM.
14. Thompson A.M., Zanobetti A., Silverman F., Baseline repeated measures from controlled human exposure studies: associations between ambient air pollution exposure and the systemic inflammatory biomarkers IL-6 and fibrinogen. Environ Health Perspect. 2010; 118(1): 120–4. doi: 10.1289/ehp.0900550.
15. De Santis V., Onufrio G., Health risks of SO2 released from coal-fired plants: a model for general evaluations. Environ Res. 1986; 41(1): 130–8.
16. Janssen A., Ruitenberg R., Buisman C., Industrial applications of new sulphur biotechnology. Water Sci Technol. 2001; 44(8): 85–90.
17. WHO. Sulfur dioxide. Air Quality Guidelines. 2nd ed. 2000. http://www.euro.who.int/__data/assets/pdf_file/0020/123086/AQG2ndEd_7_4Sulfurdioxide.pdf. Accessed June 23, 2013.
18. Deger L., Plante C., Jacques L., Active and uncontrolled asthma among children exposed to air stack emissions of sulphur dioxide from petroleum refineries in Montreal, Quebec: a cross-sectional study. Can Respir J. 2012; 19(2): 97–102.
19. Jang A-S, Yeum C-H, Son M-H. Epidemiologic evidence of a relationship between airway hyperresponsiveness and exposure to polluted air. Allergy. 2003; 58(7): 585–8.
20. WHO. Global ambient air pollution concentrations and trends. Air Quality Guidelines: Global Update 2005. 2006. http://www.euro.who.int/__data/assets/pdf_file/0005/78638/E90038.pdf. Accessed June 23, 2013.
21. Nieminen P., Panychev D., Lyalyushkin S., Environmental exposure as an independent risk factor of chronic bronchitis in northwest Russia. Int J Circumpolar Health. 2013; 72: 19742–8.
22. Pohanish R.P., Sulfur dioxide. HazMat Data for First Response, Transportation, Storage, and Security. 2nd ed. Hoboken, NJ: John Wiley & Sons, Inc; 2004: 1022.
23. Brown J.A., Haz-Map®: information on hazardous chemicals and occupational diseases: sulfur dioxide. US Natl Libr Med. 2012. http://hazmap.nlm.nih.gov/category-details?id=25&table=copytblagents. Accessed July 11, 2012.
24. HSDB. Sulfur dioxide. Natl Libr Med. 2012. http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~oZm2dk: 1. Accessed January 23, 2013.
25. Lin S., Hwang S-A, Pantea C., Kielb C., Fitzgerald E., Childhood asthma hospitalizations and ambient air sulfur dioxide concentrations in Bronx County, New York. Arch Environ Health. 2004; 59(5): 266–75. doi: 10.3200/AEOH.59.5.266-275.
26. Peden D.B., Mechanisms of pollution-induced airway disease: in vivo studies. Allergy. 1997; 52(suppl 38): 37–44.
27. Schwela D., Air pollution and health in urban areas. Rev Environ Health. 2000; 15(1-2): 13–42.
28. Sheppard D., Saisho A., Nadel J.A., Boushey H.A., Exercise increases sulfur dioxide-induced bronchoconstriction in asthmatic subjects. Am Rev Respir Dis. 1981; 123: 486–91.
29. Raulf-Heimsoth M., Hoffmeyer F., van Thriel C., Blaszkewicz M., Bünger J., Brüning T., Assessment of low dose effects of acute sulphur dioxide exposure on the airways using non-invasive methods. Arch Toxicol. 2010; 84(2): 121–7. doi: 10.1007/s00204-009-0480-5.
30. D'Amato G., Liccardi G., D'Amato M., Cazzola M., Respiratory allergic diseases induced by outdoor air pollution in urban areas. Monaldi Arch Chest Dis. 2002; 57(3-4): 161–3.
31. WHO. Sulfur Oxides and Suspended Particulate Matter (EHC 8). 1979. http://www.inchem.org/documents/ehc/ehc/ehc008.htm. Accessed June 23, 2013.
32. Takahashi Y., Miyoshi T., Higashi M., Kamioka H., Kanai Y., Neutralization of calcite in mineral aerosols by acidic sulfur species collected in China and Japan Studied by ca K-edge X-ray absorption near-edge structure. Environ Sci Technol. 2009; 43(17): 653–40. doi: 10.1021/es9010256.
33. Waller R., Brooks A., Cartwright J., An electron microscope study of particles in town air. Air Water Pollut. 1963; 7: 779–86.
34. Schlipkoter H., Bruch J., Behaviour of the lung as an organ of absorption and reaction when air-borne contaminants are inhaled. Zentralbl Bakteriol Orig B. 1976; 162(1-2): 1–17.
35. NRC. Kelly Kate, editor. Sulfur dioxide. Review of Submarine Escape Action Levels for Selected Chemicals. Washington, DC: National Academy Press; 2002: 248–81.
36. Calabrese E., Sacco C., Moore G., DiNardi S., Sulfite oxidase deficiency: a high risk factor in SO2, sulfite, and bisulfite toxicity? Med Hypotheses. 1981; 7: 133–45.
37. Gunnison A.F., Sellakumar A., Currie D., Snyder E.A., Distribution, metabolism and toxicity of inhaled sulfur dioxide and endogenously generated sulfite in the respiratory tract of normal and sulfite oxidase-deficient rats. J Toxicol Environ Health. 1987; 21(1/2): 141–62.
38. Gunnison A.F., Palmes E.D., S-sulfonates in human plasma following inhalation of sulfur dioxide. Am Ind Hyg Assoc J. 1974; 35(5): 288–91.
39. Gunnison A.F., Palmes E.D., Species variability in plasma S-sulfonate levels during and following sulfite administration. Chem Biol Interact. 1978; 21: 315–29.
40. Bechtold W.E., Waide J.J., Sandström T., Biological markers of exposure to SO2: S-sulfonates in nasal lavage. J Expo Anal Environ Epidemiol. 1993; 3(4): 371–82.
41. Acosta R., Granados J., Mourelle M., Perez-Alvarez V., Quezada E., Sulfite sensitivity: relationship between sulfite plasma levels and bronchospasm: case report. Ann Allergy. 1989; 62(5): 402–5.
42. Ameredes B.T., Translating airway biomarker information into practice: from theoretical science to applied medicine. Pulm Pharmacol Ther. 2011; 24(2): 187–92. doi: 10.1016/j.pupt.2010.09.006.
43. Winterton D.L., Kaufman J., Keener C.V., Genetic polymorphisms as biomarkers of sensitivity to inhaled sulfur dioxide in subjects with asthma. Ann Allergy Asthma Immunol. 2001; 86(2): 232–8. doi: 10.1016/S1081-1206(10)62697-X.
44. Kharitonov S.A., Barnes P.J., Clinical aspects of exhaled nitric oxide. Eur Respir J. 2000; 16: 781–92.
45. Forbes L.J., Patel M.D., Rudnicka A.R., Chronic exposure to outdoor air pollution and markers of systemic inflammation. Epidemiology. 2009; 20(2): 245–53. doi: 10.1097/EDE.0b013e318190ea3f.
46. Ghio A.J., Kim C., Devlin R.B., Concentrated ambient air particles induce mild pulmonary inflammation in healthy human volunteers. Am J Respir Crit Care Med. 2000; 162: 981–8.
47. Hoffmann B., Moebus S., Dragano N., Chronic residential exposure to particulate matter air pollution and systemic inflammatory markers. Environ Health Perspect. 2009; 117(8): 1302–8. doi: 10.1289/ehp.0800362.
48. Shima M., Air pollution and serum C-reactive protein concentration in children. J Epidemiol. 2007; 17(5): 169–76.
49. Li R., Meng Z., Effects of SO2 derivatives on expressions of MUC5AC and IL-13 in human bronchial epithelial cells. Arch Toxicol. 2007; 81(12): 867–74. doi: 10.1007/s00204-007-0212-7.
50. Li R., Meng Z., Xie J., Effects of sulfur dioxide derivatives on four asthma-related gene expressions in human bronchial epithelial cells. Toxicol Lett. 2007; 175(1-3): 71–81. doi: 10.1016/j.toxlet.2007.09.011.
51. Pelletier M., Lavastre V., Girard D., Activation of human epithelial lung a549 cells by the pollutant sodium sulfite: enhancement of neutrophil adhesion. Toxicol Sci. 2002; 69(1): 210–6.
52. Yang Y-F, Hsu J-Y, Fu L-S, Weng Y-S, Chu J-J. Asthma drugs counter-regulate interleukin-8 release stimulated by sodium sulfite in an A549 cell line. J Asthma. 2008; 46(3): 238–43. doi: 10.1080/02770900802628508.
53. Nadel J., Role of epidermal growth factor receptor activation in regulating mucin synthesis. Respir Res. 2001; 2(2): 85–9.
54. Burgel P-R, Nadel J., Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium. Thorax. 2004; 59(11): 992–6. doi: 10.1136/thx.2003.018879.
55. Wegner C.D., Gundel R.H., Reilly P., Haynes N., Letts L.G., Rothlein R., Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science. 1990; 247(4941): 456–9.
56. Park G.Y., Christman J.W., Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases. Am J Physiol Lung Cell Mol Physiol. 2006; 290(5): L797–805. doi: 10.1152/ajplung.00513.2005.
57. Lim Y.J., Na H.S., Yun Y.S., Suppressive effects of ginsan on the development of allergic reaction in murine asthmatic model. Int Arch Allergy Immunol. 2009; 150(1): 32–42. doi: 10.1159/000210378.
58. Misawa M., Nakano E., Airway constriction by xanthine/xanthine oxidase in guinea pigs in vivo. J Toxicol Environ Health. 1993; 39(2): 193–205.
59. Park J-K, Kim Y-K, Lee S-R, Cho S-H, Min K-U, Kim Y-Y. Repeated exposure to low levels of sulfur dioxide (SO2) enhances the development of ovalbumin-induced asthmatic reactions in guinea pigs. Ann Allergy Asthma Immunol. 2001; 86(1): 62–7.
60. Li Y., Wang J., He H.Y., Immunohistochemical demonstration of airway epithelial cell markers of guinea pig. Tissue Cell. 2011; 43(5): 283–90. doi: 10.1016/j.tice.2011.05.003.
61. Handley D., DeLeo J., Havill A., Induction by aerosol allergen of sustained and nonspecific IgE-mediated airway hyperreactivity in the guinea pig. Agents Actions. 1992; 37(3-4): 201–3.
62. Ramos-Ramírez P., Campos M., Martínez-Cordero E., Bazán-Perkins B., García-Zepeda E., Antigen-induced airway hyperresponsiveness in absence of broncho-obstruction in sensitized guinea pigs. Exp Lung Res. 2013; 39(3): 136–45.
63. Cai C., Xu J., Zhang M., Prior SO2 exposure promotes airway inflammation and subepithelial fibrosis following repeated ovalbumin challenge. Clin Exp Allergy. 2008; 38(10): 1680–7. doi: 10.1111/j.1365-2222.2008.03053.x.
64. Lin H-K, Tsai J-J, Wen M-C, Tsai M-C, Chen C-J, Fu L-S. Sodium sulfite aggravated allergic sensitization and airway inflammation in mite allergen sensitized BALB/c mice. Hum Exp Toxicol. 2011; 30(10): 1682–9. doi: 10.1177/0960327111398673.
65. Meng Z., Qin G., Zhang B., Oxidative damage of sulfur dioxide inhalation on lungs and hearts of mice. Environ Res. 2003; 93(3): 285–92. doi: 10.1016/S0013–9351(03)00045-8.
66. Meng Z., Li R., Zhang X., Levels of sulfite in three organs from mice exposed to sulfur dioxide. Inhal Toxicol. 2005; 17(6): 309–13. doi: 10.1080/08958370590922634.
67. Meng Z., Liu Y., Wu D., Effect of sulfur dioxide inhalation on cytokine levels in lungs and serum of mice. Inhal Toxicol. 2005; 17(6): 303–7. doi: 10.1080/08958370590922625.
68. Beck-Speier I., Hinze H., Holzer H., Effect of sulfite on the energy metabolism of mammalian tissues in correlation to sulfite oxidase activity. Biochim Biophys Acta. 1985; 841: 81–9.
69. Cabré F., Marín C., Cascante M., Canela E.I., Occurrence and comparison of sulfite oxidase activity in mammalian tissues. Biochem Med Metab Biol. 1990; 43(2): 159–62.
70. Maier K.L., Wippermann U., Leuschel L., Xenobiotic-metabolizing enzymes in the canine respiratory tract. Inhal Toxicol. 1999; 11: 19–35.
71. Gavett S.H., Wills-Karp M., Elevated lung G protein levels and muscarinic receptor affinity in a mouse model of airway hyperreactivity. Am J Physiol. 1993; 265(5 pt 1): L493–500.
72. Bai J., Meng Z., Effects of sulfur dioxide on apoptosis-related gene expressions in lungs from rats. Regul Toxicol Pharmacol. 2005; 43(3): 272–9. doi: 10.1016/j.yrtph.2005.09.002.
73. Li R., Meng Z., Xie J., Effects of sulfur dioxide on the expressions of MUC5AC and ICAM-1 in airway of asthmatic rats. Regul Toxicol Pharmacol. 2007; 48(3): 284–91. doi: 10.1016/j.yrtph.2007.04.009.
74. Li R., Meng Z., Xie J., Effects of sulfur dioxide on the expressions of EGF. Arch Environ Contam Toxicol. 2008; 54(4): 748–57. doi: 10.1007/s00244-007–9054-9.
75. Qin G., Meng Z., Effect of sulfur dioxide inhalation on CYP1A1 and CYP1A2 in rat liver and lung. Toxicol Lett. 2005; 160(1): 34–42. doi: 10.1016/j.toxlet.2005.06.002.
76. Xie J., Li R., Fan R., Meng Z., Effects of sulfur dioxide on expressions of p53, bax and bcl-2 in lungs of asthmatic rats. Inhal Toxicol. 2009; 21(11): 952–7. doi: 10.1080/08958370802629602.
77. Yun Y., Hou L., Sang N., SO(2) inhalation modulates the expression of pro-inflammatory and pro-apoptotic genes in rat heart and lung. J Hazard Mater. 2011; 185(1): 482–8. doi: 10.1016/j.jhazmat.2010.09.057.
78. Abdulamir A.S., Hafidh R.R., Abubakar F., Abbas K.A., Changing survival, memory cell compartment, and T-helper balance of lymphocytes between severe and mild asthma. BMC Immunol. 2008; 9: 73–82. doi: 10.1186/1471-2172-9–73.
79. Suzuki S., Matsukura S., Takeuchi H., Increase in reactive oxygen metabolite level in acute exacerbations of asthma. Int Arch Allergy Immunol. 2008; 146(suppl 1): 67–72. doi: 10.1159/000126064.
80. Beck-Speier I., Liese J.G., Belohradsky B.H., Godleski J.J., Sulfite stimulates NADPH oxidase of human neutrophils to produce active oxygen radicals via protein kinase C and Ca2+/calmodulin pathways. Free Radic Biol Med. 1993; 14: 661–8.
81. Kienast K., Müller-Quernheim J., Knorst M., Lubjuhn S., Ferlinz R., In vitro study of human alveolar macrophage and peripheral blood mononuclear cell reactive oxygen-intermediates release induced by sulfur dioxide at different concentrations. Lung. 1994; 172(6): 335–45.
82. Labbé P., Pelletier M., Omara F.O., Girard D., Functional responses of human neutrophils to sodium sulfite (Na2SO3) in vitro. Hum Exp Toxicol. 1998; 17(11): 600–5.
83. Collaco C.R., Hochman D.J., Goldblum R.M., Brooks E.G., Effect of sodium sulfite on mast cell degranulation and oxidant stress. Ann Allergy Asthma Immunol. 2006; 96(4): 550–6. doi: 10.1016/S1081-1206(10)63549-1.
84. Yang I., Fong K., Zimmerman P., Holgate S., Holloway J., Genetic susceptibility to the respiratory effects of air pollution. Thorax. 2008; 63: 555–63 doi: 10.1136/thx. 2007.079426.
85. Ahmed M.N., Codipilly C., Hogg N., Auten R.L., The protective effect of overexpression of extracellular superoxide dismutase on nitric oxide bioavailability in the lung after exposure to hyperoxia stress. Exp Lung Res. 2011; 37: 10–7.
86. Ghosh S., Erzurum S.C., Nitric oxide metabolism in asthma pathophysiology. Biochim Biophys Acta. 2011; 1810(11): 1008–16. doi: 10.1016/j.bbagen.2011.06.009.
87. Zhao H., Xu X., Na J., Protective effects of salicylic acid and vitamin C on sulfur dioxide-induced lipid peroxidation in mice. Inhal Toxicol. 2008; 20(9): 865–71. doi: 10.1080/08958370701861512.
88. Fattman C., Schaefer L., Oury T., Extracellular superoxide dismutase in biology and medicine. Free Radic Biol Med. 2003; 35(3): 236–56 doi: 10.1016/S0891-5849(03)002750-2.
89. Tan R.J., Fattman C.L., Watkins S.C., Oury T.D., Redistribution of pulmonary EC-SOD after exposure to asbestos. J Appl Physiol. 2004; 97(5): 2006–13. doi: 10.1152/japplphysiol.00480.2004.
90. Xia Z.W., Xu L.Q., Zhong W.W., Heme oxygenase-1 attenuates ovalbumin-induced airway inflammation by up-regulation of foxp3 T-regulatory cells, interleukin-10, and membrane-bound transforming growth factor-1. Am J Pathol. 2007; 171(6): 1904–14. doi: 10.2353/ajpath.2007.070096.
91. Brehm J.M., Schuemann B., Fuhlbrigge A.L.,; Childhood Asthma Management Program Research Group. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J Allergy Clin Immunol. 2010; 126(1): 52–8 doi: 10.1016/j.jaci.2010.03.043.
92. Cohen H.A., Neuman I., Nahum H., Blocking effect of vitamin C in exercise-induced asthma. Arch Pediatr Adolesc Med. 1997; 151: 367–70
93. Fogarty A., Lewis S.A., Scrivener S.L., Corticosteroid sparing effects of vitamin C and magnesium in asthma: a randomised trial. Respir Med. 2006; 100(1): 174–9. doi: 10.1016/j.rmed.2005.03.038.
94. Hollams E.M., Hart P.H., Holt B.J., Vitamin D and atopy and asthma phenotypes in children: a longitudinal cohort study. Eur Respir J. 2011; 38(6): 1320–7. doi: 10.1183/09031936.00029011.
95. Redlich C.A., Grauer J.N., Van Bennekum A.M., Clever S.L., Ponn R.B., Blaner W.S., Characterization of carotenoid, vitamin A, and alpha-tocopheral levels in human lung tissue and pulmonary macrophages. Am J Respir Crit Care Med. 1996; 154(5): 1436–43. doi: 10.1164/ajrccm.154.5.8912761.
96. Schachter E.N., Schlesinger A., The attenuation of exercise-induced bronchospasm by ascorbic acid. Ann Allergy. 1982; 49(3): 146–51.
97. Tecklenburg S.L., Mickleborough T.D., Fly A.D., Bai Y., Stager J.M., Ascorbic acid supplementation attenuates exercise-induced bronchoconstriction in patients with asthma. Respir Med. 2007; 101(8): 1770–8. doi: 10.1016/j.rmed.2007.02.014.
98. Trenga C.A., Koenig J.Q., Williams P.V., Sulphur dioxide sensitivity and plasma antioxidants in adult subjects with asthma. Occup Environ Med. 1999; 56(8): 544–7.
99. Trenga C.A., Koenig J.Q., Williams P.V., Dietary antioxidants and ozone-induced bronchial hyperresponsiveness in adults with asthma. Arch Environ Health. 2001; 56(3): 242–9.
100. Wu A.C., Tantisira K., Li L., Fuhlbrigge A.L., Weiss S.T., Litonjua A., Effect of vitamin D and inhaled corticosteroid treatment on lung function in children. Am J Respir Crit Care Med. 2012; 186(6): 508–13. doi: 10.1164/rccm.201202-0351OC.
101. Castro M., King T.S., Kunselman S.J., National Heart, Lung, and Blood Institute's AsthmaNet. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA. 2014; 311(20): 2083–91. doi: 10.1001/jama.2014.5052.
102. Meggs W.J., Neurogenic inflammation and sensitivity to environmental chemicals. Environ Health Perspect. 1993; 101(3): 234–8.
103. Aoki H., Mogi C., Okajima F., Ionotropic and metabotropic proton-sensing receptors involved in airway inflammation in allergic asthma. Mediators Inflamm. 2014; 2014: 712962. doi: 10.1155/2014/712962.
104. McLeod R.L., Jia Y., McHugh N.A., Sulfur-dioxide exposure increases TRPV1-mediated responses in nodose ganglia cells and augments cough in guinea pigs. Pulm Pharmacol Ther. 2007; 20(6): 750–7. doi: 10.1016/j.pupt.2006.09.003.
105. Bannenberg G., Atzori L., Xue J., Sulfur dioxide and sodium metabisulfite induce bronchoconstriction in the isolated perfused and ventilated guinea pig lung via stimulation of capsaicin-sensitive sensory nerves. Respiration. 1994; 61(3): 130–7.
106. Bhakta N.R., Woodruff P.G., Human asthma phenotypes: from the clinic, to cytokines, and back again. Immunol Rev. 2011; 242(1): 220–32. doi: 10.1111/j.1600-065X.2011.01032.x.
107. Pawelek-Krombholz D., Konecki J., Kaminski M., Helewski K., Effect of sulfuric acid vapors on the respiratory system. Med Pr. 1985; 36(4): 229–35.
108. Hunt J.F., Fang K., Malik R., Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med. 2000; 161(3 pt 1): 694–9.
109. Ricciardolo F.L., Gaston B., Hunt J., Acid stress in the pathology of asthma. J Allergy Clin Immunol. 2004; 113(4): 610–9. doi: 10.1016/j.jaci.2003.12.034.
110. Wood P.R., Hill V.L., Burks M.L., Mycoplasma pneumoniae in children with acute and refractory asthma. Ann Allergy Asthma Immunol. 2013; 110(5): 328–34. doi: 10.1016/j.anai.2013.01.022.
111. Barnes P.J., Neurogenic inflammation in the airways. Respir Physiol. 2001; 125(1-2): 145–54.
112. Fujimaki H., Kurokawa Y., Kunugita N., Kikuchi M., Sato F., Arashidani K., Differential immunogenic and neurogenic inflammatory responses in an allergic mouse model exposed to low levels of formaldehyde. Toxicology. 2004; 197(1): 1–13. doi: 10.1016/j.tox.2003.11.015.
113. Lin H., Qi H., Fang L., Li S., Li Z., Xie B., To explore the mechanisms of neurogenic inflammation and airway hyperresponsiveness of rat by inhaled sulfur. Chinese J Appl Physiol. 2009; 25(1): 113–6.
114. US EPA. Formaldehyde: Hazard Summary. 2003. http://www.epa.gov/ttn/atw/hlthef/formalde.html. Accessed June 27, 2014.
115. WHO. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Volume 88 Formaldehyde, 2-Butoxyethanol and 1-Tert-Butoxypropan-2-Ol. 2006: 1–9 http://monographs.iarc.fr/ENG/Monographs/vol88/volume88.pdf.
116. WHO. International Program on Chemical Safety, Environmental Health Criteria 89: Formaldehyde. 1999. http://www.inchem.org/documents/ehc/ehc/ehc89.htm. Accessed June 27, 2014.
117. Dao Nguyen X., Robinson D.S., Fluticasone propionate increases CD4+CD25+ T regulatory cell suppression of allergen-stimulated CD4+CD25+T cells by an IL-10-dependent mechanism. J Allergy Clin Immunol. 2004; 114(2): 296–301. doi: 10.1016/j.jaci.2004.04.048.
118. Peek E.J., Richards D.F., Faith A., Interleukin-10-secreting “regulatory” T cells induced by glucocorticoids and beta2-agonists. Am J Respir Cell Mol Biol. 2005; 33(1): 105–11. doi: 10.1165/rcmb.2005-0100OC.
119. Stelmach I., Jerzynska J., Kuna P., A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and beta-agonist treatment on IL-10 serum levels in children with asthma. Clin Exp Allergy. 2002; 32(2): 264–9.
120. Kühn R., Löhler J., Rennick D., Rajewsky K., Müller W., Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993; 75(2): 263–74.
121. Tournoy K.G., Kips J.C., Pauwels R.A., Endogenous interleukin-10 suppresses allergen-induced airway inflammation and nonspecific airway responsiveness. Clin Exp Allergy. 2000; 30(6): 775–83.
122. Vissers J.L., van Esch B.C., Jeurink P.V., Hofman G.A., van Oosterhout A.J., Stimulation of allergen-loaded macrophages by TLR9-ligand potentiates IL-10-mediated suppression of allergic airway inflammation in mice. Respir Res. 2004; 5: 21–28 doi: 10.1186/1465-9921-5-21.
123. Ameredes B.T., Zamora R., Gibson K.F., Increased nitric oxide production by airway cells of sensitized and challenged IL-10 knockout mice. J Leukoc Biol. 2001; 70(5): 730–6.
124. Mäkelä M.J., Kanehiro A., Borish L., IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization. Proc Natl Acad Sci U S A. 2000; 97(11): 6007–12. doi: 10.1073/pnas.100118997.
125. Justice J.P., Shibata Y., Sur S., Mustafa J., Fan M., Van Scott M.R., IL-10 gene knockout attenuates allergen-induced airway hyperresponsiveness in C57BL/6 mice. Am J Physiol Lung Cell Mol Physiol. 2001; 280: L363–8.
126. Ameredes B.T., Zamora R., Sethi J.M., Alterations in nitric oxide and cytokine production with airway inflammation in the absence of IL-10. J Immunol. 2005; 175(2): 1206–13.
127. Ogawa Y., Duru E.A., Ameredes B.T., Role of IL-10 in the resolution of airway inflammation. Curr Mol Med. 2008; 8(5): 437–45.
128. Till S.J., Francis J.N., Nouri-Aria K., Durham S.R., Mechanisms of immunotherapy. J Allergy Clin Immunol. 2004; 113(6): 1025–34. doi: 10.1016/j.jaci.2004.03.024.
129. Wei W., Liu Y., Wang Y., Induction of CD4+CD25+Foxp3+IL-10+ T cells in HDM-allergic asthmatic children with or without SIT. Int Arch Allergy Immunol. 2010; 153(1): 19–26.
130. Lou W., Wang C., Wang Y., Han D., Zhang L., Responses of CD4(+) CD25(+) Foxp3(+) and IL-10-secreting type I T regulatory cells to cluster-specific immunotherapy for allergic rhinitis in children. Pediatr Allergy Immunol. 2012; 23(2): 140–9 doi: 10.1111/j.1399-3038.2011.01249.x.
131. Almolki A., Taillé C., Martin G.F., Heme oxygenase attenuates allergen-induced airway inflammation and hyperreactivity in guinea pigs. Am J Physiol Lung Cell Mol Physiol. 2004; 287(1): L26–34. doi: 10.1152/ajplung.00237.2003.
132. Ryter S.W., Choi A.M., Heme oxygenase-1: redox regulation of a stress protein in lung and cell culture models. Antioxid Redox Signal. 2005; 7(1-2): 80–91. doi: 10.1089/ars.2005.7.80.
133. Xia Z.W., Zhong W.W., Xu L.Q., Heme oxygenase-1-mediated CD4+CD25high regulatory T cells suppress allergic airway inflammation. J Immunol. 2006; 177(9): 5936–45
134. Kuo M.L., Huang J.L., Yeh K.W., Li P.S., Hsieh K.H., Evaluation of T1/T2 ratio and cytokine production profile during acute exacerbation and convalescence in asthmatic children. Ann Allergy Asthma Immunol. 2001; 86(3): 272–6. doi: 10.1016/S1081-1206(10)63297-8.
135. Borges V.M., Vandivier R.W., McPhillips K.A., TNFalpha inhibits apoptotic cell clearance in the lung, exacerbating acute inflammation. Am J Physiol Lung Cell Mol Physiol. 2009; 297(4): L586–95. doi: 10.1152/ajplung.90569.2008.
136. Sierra-Filardi E., Vega M.A., Sánchez-Mateos P., Corbí A.L., Puig-Kröger A., Heme oxygenase-1 expression in M-CSF-polarized M2 macrophages contributes to LPS-induced IL-10 release. Immunobiology. 2010; 215(9-10): 788–95 doi: 10.1016/j.imbio.2010.05.020.
137. US EPA. Sulfur Dioxide (SO2) Primary Standards – Table of Historical SO2 NAAQS. 2013. http://www.epa.gov/ttn/naaqs/standards/so2/s_so2_history.html. Accessed June 24, 2013.